| P50 | author | Pierre Bedossa | Q42979649 |
| P2860 | cites work | An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group | Q29614898 |
| | Mechanisms of hepatic fibrogenesis | Q29619336 |
| | The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization | Q33846319 |
| | Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study | Q34317204 |
| | Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression | Q34365464 |
| | Long-term therapy for chronic hepatitis B: hepatitis B virus DNA suppression leading to cirrhosis reversal | Q38097858 |
| | Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible? | Q38174255 |
| | Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors | Q39807542 |
| | Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. | Q42947269 |
| | Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. | Q42979579 |
| | Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma | Q43033643 |
| | Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort | Q43693290 |
| | Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years | Q43914060 |
| | Histological outcome during long-term lamivudine therapy. | Q44269261 |
| | Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking | Q44929886 |
| | Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension. | Q45925945 |
| | Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas | Q57782611 |
| | Improving performance of liver biopsy in fibrosis assessment | Q57782677 |
| P921 | main subject | Hepatitis B virus | Q6844 |
| | hepatitis B | Q6853 |
| | liver cirrhosis | Q147778 |
| P304 | page(s) | 78-81 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Liver International | Q15765078 |
| P1476 | title | Reversibility of hepatitis B virus cirrhosis after therapy: who and why? | |
| P478 | volume | 35 Suppl 1 | |